首页> 外国专利> Mutations in the mineralocorticoid receptor ligand binding domain polypeptide that permit structural determination of low affinity ligand complexes and screening methods employing same

Mutations in the mineralocorticoid receptor ligand binding domain polypeptide that permit structural determination of low affinity ligand complexes and screening methods employing same

机译:盐皮质激素受体配体结合结构域多肽中的突变,可实现低亲和力配体复合物的结构测定以及使用该突变体的筛选方法

摘要

An isolated mineralocorticoid receptor (MR) polypeptide, or functional portion thereof, having one or more mutations that alter the solubility or crystal-forming properties and confer the ability to generate soluble protein complexes with the MR and ligands that only weakly bind the native polypeptide, and a polynucleotide encoding it are disclosed. Representative mutations are C808S and S810L substitutions. Expression of the MR polypeptide in E. coli is also provided. A solved three-dimensional crystal structure of an MR ligand binding domain polypeptide is also disclosed, along with a crystalline form of the MR ligand binding domain polypeptide. Methods of modeling one or more molecular interactions of a native NR with a ligand having low affinity for the native NR utilizing a mutated MR, designing modulators of the biological activity of MR and other nuclear receptor, steroid receptor and glucocorticoid receptor polypeptides and nuclear receptor, steroid receptor and glucocorticoid receptor ligand binding domain polypeptides are also disclosed.
机译:一种分离的盐皮质激素受体(MR)多肽或其功能部分,具有一个或多个突变,可改变溶解度或晶体形成特性,并赋予与MR和仅弱结合天然多肽的配体生成可溶性蛋白质复合物的能力,并且公开了编码它的多核苷酸。代表性突变是C808S和S810L取代。 MR多肽在中的表达。还提供了。还公开了MR配体结合域多肽的解析的三维晶体结构,以及MR配体结合域多肽的晶体形式。利用突变的MR模拟天然NR与对天然NR具有低亲和力的配体的一种或多种分子相互作用的方法,设计MR和其他核受体,类固醇受体和糖皮质激素受体多肽和核受体的生物学活性的调节剂,还公开了类固醇受体和糖皮质激素受体配体结合结构域多肽。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号